next-generation microbicide

Microbicide products based on the same antiretroviral (ARV) drugs used successfully to treat HIV and to prevent mother-to-child-transmission (PMTCT) of HIV. The first next-generation microbicide was proven efficacious at preventing HIV infection by the CAPRISA 004 trial.